⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 20, 2024HeliyonOpen Access

Mechanisms of Yiai Fuzheng formula in the treatment of triple-negative breast cancer based on UPLC-Q-Orbitrap-HRMS, network pharmacology, and experimental validation

Ruijie Li Haoliang Ke Pan Liu Qian Yang Yuxin Li Longzhu Ke Xiuping Wang Chaoyan Wu Yingwen Zhang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Yiai Fuzheng formula (YAFZF), as a Traditional Chinese Medicine (TCM) prescription, has been used widely at Zhongnan Hospital of Wuhan University for its therapeutic effects and high safety on triple-negative breast cancer (TNBC).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e5b9b2b6db643587551f72 https://doi.org/10.1016/j.heliyon.2024.e36579

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Yiai Fuzheng decoction inhibits triple-negative breast cancer by remodeling the immune microenvironment2025 · 2 citations
2Fuzheng Yiai Formula and its Key Components Inhibited PCa by TP53/SLC7A11/GPX4-Induced FerroptosisOriginal Research · 2026
3Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer2024 · 3 citations
4Knockdown and Overexpression Experiments to Investigate the Inhibitory Mechanism of Fuzheng Xiaozheng Prescription, an Effective Chinese Herbal Formula for the Clinical Treatment of Hepatocellular Carcinoma2024 · 4 citations
5Effect of Fuzheng Pill on Liver Cancer via the Mitochondrial Apoptosis PathwayIn Vitro Study · 2026

Effect of the Fu Zheng Method Applied by Hong-Feng CHEN on the Quality of Life in TNBC Patients and Empirical Research Based on Data Mining2018
Efficacy of Fuzheng Quxie Formula against postoperative metastasis of lung cancer in stage IIA-IIIA with negative driver genes: study protocol for a multi-centre, double-blind, randomized controlled trial (Preprint)2024
Abstract 3664: A novel 4-herb traditional Chinese medicine formula inhibits metastasis of triple-negative breast cancer2026
Unusual difficulty in identifying the source of infection leading to the misdiagnosis of secondary peritonitis: A case report and review of the literatureHeliyon · 2026
API5 protein impacts tumor progression, metastasis, and immune evasionHeliyon · 2026

More from Heliyon

More from Wuhan University

More from Zhongnan Hospital of Wuhan University

More from Hubei University of Chinese Medicine